These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 21459633)
1. The immunohistochemical profile of oral inflammatory myofibroblastic tumors. Salgueiredo-Giudice F; Fornias-Sperandio F; Martins-Pereira E; da Costa dal Vechio AM; de Sousa SC; dos Santos-Pinto-Junior D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jun; 111(6):749-56. PubMed ID: 21459633 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X; Montgomery E; Sun B Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254 [TBL] [Abstract][Full Text] [Related]
3. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder]. Zhang YH; Zhang XR; Yu J; Li HL Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662 [No Abstract] [Full Text] [Related]
6. Clinicopathological and immunohistochemical features of oral spindle cell carcinoma. Romañach MJ; Azevedo RS; Carlos R; de Almeida OP; Pires FR J Oral Pathol Med; 2010 Apr; 39(4):335-41. PubMed ID: 20002980 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic study of sinonasal inflammatory myofibroblastic tumor]. He CY; Jin YL; Yang DM; Liu HG Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):166-71. PubMed ID: 20450762 [TBL] [Abstract][Full Text] [Related]
8. Low-grade myofibroblastic sarcoma of the maxillary region in a dog. Tsuchiya T; Suzuki K; Hojo Y; Shiraki A; Imaoka M; Shibutani M; Mitsumori K J Comp Pathol; 2012 Jul; 147(1):42-5. PubMed ID: 21996034 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change. Shintaku M; Fukushima A Pathol Int; 2006 Oct; 56(10):625-8. PubMed ID: 16984620 [TBL] [Abstract][Full Text] [Related]
10. [Inflammatory myofibroblastic tumor of bladder: a clinicopathologic study of five cases]. Sun K; Wang ZM; Xu LJ; Teng XD; Yao HT; Ren GP Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):605-8. PubMed ID: 18070449 [TBL] [Abstract][Full Text] [Related]
11. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma. Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory myofibroblastic tumor of the alveolar mucosa of the mandible. Johann AC; Caldeira PC; Abdo EN; Sousa SO; Aguiar MC; Mesquita RA Minerva Stomatol; 2008; 57(1-2):59-63. PubMed ID: 18427372 [TBL] [Abstract][Full Text] [Related]
13. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study. Ceballos KM; Nielsen GP; Selig MK; O'Connell JX Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549 [TBL] [Abstract][Full Text] [Related]
14. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]
15. Fibronectin as an adjuvant in the diagnosis of oral inflammatory myofibroblastic tumor. Xavier FC; Rocha AC; Sugaya NN; dos Santos-Pinto D; de Sousa SC Med Oral Patol Oral Cir Bucal; 2009 Dec; 14(12):e635-9. PubMed ID: 19680189 [TBL] [Abstract][Full Text] [Related]
16. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. Etemad-Moghadam S; Khalili M; Tirgary F; Alaeddini M J Oral Pathol Med; 2009 Sep; 38(8):639-43. PubMed ID: 19473444 [TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological features of inflammatory myofibroblastic tumors of the lung]. Yang H; Xie R; Xiao J; Zhang S Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):116-9. PubMed ID: 21114933 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]